Literature DB >> 14671620

Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab.

José Petit1, Mercedes Clavo, Alberto Fernández de Sevilla, Eva González-Barca, Eva Domingo-Doménech, Albert Grañena.   

Abstract

Cold agglutinin immunohaemolytic anaemia (CAIA) responds poorly to standard treatment. We report a case of marginal zone lymphoma complicated by CAIA that responded to rituximab after failing to respond to corticosteroids and chlorambucil.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671620     DOI: 10.1038/sj.thj.6200329

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  2 in total

Review 1.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2011-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.